PUBLIC CONTRACT · 2019
P259-2019-202 - Osimertinib e fulvestrant
- Contract value
- €886,643.34
- Signed on
- 25 November 2019
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6231065PUBLISHED SUBJECT
P259-2019-202 - Aquisição de Medicamentos ao Abrigo do Acordo Quadro 2017/6 para as Instituições do SNS
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Astrazeneca - Produtos Farmacêuticos, Lda · Tax ID 502942240
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €886,643.34
- Procedure base price
- €5,345,459.31
- Total effective price
- Not reported on Portal BASE
- Publication date
- 21 January 2020
- Award date
- 8 November 2019
- Signing date
- 25 November 2019
- Performance period
- 366 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4241825
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.